Axsome Therapeutics (AXSM) Change in Account Payables (2015 - 2026)
Axsome Therapeutics recorded quarterly Change in Account Payables of $41.2 million in Q1 2026, up 263.97% quarter-over-quarter from $11.3 million in Q4 2025, and up 201.31% year-over-year from $13.7 million in Q1 2025.
Axsome Therapeutics' Change in Account Payables history runs 12 years deep, the most recent figure standing at $41.2 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 201.31% year-over-year to $41.2 million; the TTM figure through Mar 2026 stood at $21.0 million (down 33.97% YoY), while the FY2025 annual figure was -$6.5 million, down 120.63% from the prior year.
- Change in Account Payables came in at $41.2 million for Q1 2026 at Axsome Therapeutics, up from $11.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $41.2 million in Q1 2026 to a low of -$37.4 million in Q3 2025.
- A 5-year average of $5.5 million and a median of $7.2 million in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 11172.43% in 2022 and tumbled 1383.93% in 2025, its largest moves.
- Axsome Therapeutics' Change in Account Payables stood at $25.8 million in 2022, then tumbled by 55.04% to $11.6 million in 2023, then tumbled by 33.13% to $7.7 million in 2024, then jumped by 46.05% to $11.3 million in 2025, then surged by 263.97% to $41.2 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $41.2 million, $11.3 million, and -$37.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 41.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.17 Mn |
| Mar 31, 2026 | 41.17 Mn |
| Dec 31, 2025 | 11.31 Mn |
| Dec 31, 2025 | 11.31 Mn |
| Sep 30, 2025 | -37.40 Mn |
| Sep 30, 2025 | -37.40 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Mar 31, 2025 | 13.66 Mn |
| Mar 31, 2025 | 13.66 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 7.55 Mn |
| Jun 30, 2024 | 7.55 Mn |
| Mar 31, 2024 | 13.11 Mn |
| Mar 31, 2024 | 13.11 Mn |
| Dec 31, 2023 | 11.58 Mn |
| Dec 31, 2023 | 11.58 Mn |
| Sep 30, 2023 | -13.86 Mn |
| Sep 30, 2023 | -13.86 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | -2.84 Mn |
| Mar 31, 2023 | -2.84 Mn |
| Dec 31, 2022 | 25.76 Mn |
| Dec 31, 2022 | 25.76 Mn |
| Sep 30, 2022 | -6.59 Mn |
| Sep 30, 2022 | -6.59 Mn |
| Jun 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 6.84 Mn |
| Mar 31, 2022 | -554,000.00 |
| Mar 31, 2022 | -554,000.00 |
| Dec 31, 2021 | -232,659.00 |
| Dec 31, 2021 | -232,659.00 |
| Sep 30, 2021 | 1.77 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | -3.01 Mn |
| Jun 30, 2021 | -3.01 Mn |
| Mar 31, 2021 | 1.12 Mn |
| Mar 31, 2021 | 1.12 Mn |
| Dec 31, 2020 | 2.19 Mn |
| Dec 31, 2020 | 2.19 Mn |
| Sep 30, 2020 | 1.95 Mn |
| Sep 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | -2.83 Mn |
| Jun 30, 2020 | -2.83 Mn |
| Mar 31, 2020 | 1.25 Mn |
| Mar 31, 2020 | 1.25 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 3.31 Mn |
| Sep 30, 2019 | 3.31 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Mar 31, 2019 | -253,060.00 |
| Mar 31, 2019 | -253,060.00 |
| Dec 31, 2018 | -480,124.00 |
| Dec 31, 2018 | -480,124.00 |
| Sep 30, 2018 | 992,191.00 |
| Sep 30, 2018 | 992,191.00 |
| Jun 30, 2018 | -699,414.00 |
| Jun 30, 2018 | -699,414.00 |
| Mar 31, 2018 | 439,136.00 |
| Mar 31, 2018 | 439,136.00 |
| Dec 31, 2017 | 492,457.00 |
| Dec 31, 2017 | 492,457.00 |
| Sep 30, 2017 | -1.10 Mn |
| Sep 30, 2017 | -1.10 Mn |
| Jun 30, 2017 | -702,057.00 |
| Jun 30, 2017 | -702,057.00 |
| Mar 31, 2017 | 659,529.00 |
| Mar 31, 2017 | 659,529.00 |
| Dec 31, 2016 | 213,589.00 |
| Dec 31, 2016 | 213,589.00 |
| Sep 30, 2016 | 832,546.00 |
| Sep 30, 2016 | 832,546.00 |
| Jun 30, 2016 | 1.20 Mn |
| Jun 30, 2016 | 1.20 Mn |
| Mar 31, 2016 | -61,941.00 |
| Mar 31, 2016 | -61,941.00 |
| Dec 31, 2015 | 1.15 Mn |
| Dec 31, 2015 | 1.15 Mn |
| Sep 30, 2015 | -330,416.00 |
| Sep 30, 2015 | -330,416.00 |
| Jun 30, 2015 | -167,387.00 |
| Jun 30, 2015 | -167,387.00 |
| Mar 31, 2015 | 483,669.00 |
| Mar 31, 2015 | 483,669.00 |